Replay of
OR-Live.com Presents:
da Vinci® Surgery for Kidney Disease
Live Webcast of da Vinci® Partial Nephrectomy
December 6, 2007
5:00 PM EST
(22:00 UTC)
From Henry Ford Hospital's Vattikuti Urology Institute, Detroit, MI
Detroit, MI -- (MARKET WIRE) - 11/8/07 -- OR-Live.com and Henry Ford Hospital will present a live Webcast of a da Vinci® (Robotic) Partial Nephrectomy from the Henry Ford Hospital's Vattikuti Urology Institute on December 6, 2007 at 5 PM (ET).
Craig Rogers, M.D., Director of Robotic Renal Surgery at Henry Ford Hospital and Director of Urologic Oncology at Henry Ford West Bloomfield Hospital, will perform this minimally invasive procedure using the da Vinci® S™ Surgical System. James Peabody, M.D., Senior Staff Surgeon of the Vattikuti Urology Institute, will moderate this event to explain critical portions of the surgery and answer e-mail questions from viewers.
da Vinci® (NASDAQ: ISRG) is a breakthrough robotic system designed to transcend the limitations of both traditional open surgery and conventional laparoscopy—thereby expanding the surgeon's capabilities and providing patients a minimally invasive option for many complex procedures. da Vinci® Partial Nephrectomy represents a state-of-the-art, minimally invasive approach to surgically remove kidney tumors while preserving healthy renal tissue necessary for normal kidney function.
Detroit, MI -- (MARKET WIRE) - 11/8/07 -- OR-Live.com and Henry Ford Hospital will present a live Webcast of a da Vinci® (Robotic) Partial Nephrectomy from the Henry Ford Hospital's Vattikuti Urology Institute on December 6, 2007 at 5 PM (ET).
Craig Rogers, M.D., Director of Robotic Renal Surgery at Henry Ford Hospital and Director of Urologic Oncology at Henry Ford West Bloomfield Hospital, will perform this minimally invasive procedure using the da Vinci® S™ Surgical System. James Peabody, M.D., Senior Staff Surgeon of the Vattikuti Urology Institute, will moderate this event to explain critical portions of the surgery and answer e-mail questions from viewers.
da Vinci® (NASDAQ: ISRG) is a breakthrough robotic system designed to transcend the limitations of both traditional open surgery and conventional laparoscopy—thereby expanding the surgeon's capabilities and providing patients a minimally invasive option for many complex procedures. da Vinci® Partial Nephrectomy represents a state-of-the-art, minimally invasive approach to surgically remove kidney tumors while preserving healthy renal tissue necessary for normal kidney function.
